DO
SUPN icon

denkapparat Operations’s Supernus Pharmaceuticals SUPN Stock Holding History

denkapparat Operations’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Hold
6,202
– – 0.09% 336
2026
Q1 		$321K Hold
6,202
– – 0.13% 264
2025
Q4 		$308K Hold
6,202
– – 0.17% 235
2025
Q3 		$296K Buy
+6,202
New +$250K 0.19% 206
2025
Q2 		– Sell
-6,202
Closed -$203K – 268
2025
Q1 		$203K Buy
+6,202
New +$220K 0.22% 205

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

denkapparat Operations's SUPN Position: Q2 2026 in Review

denkapparat Operations held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 6,202 shares worth $288K. The position accounts for 0.09% of the portfolio, ranked #336.

denkapparat Operations first reported a position in SUPN in Q1 2025 and has held it in 5 quarters since. The position peaked at $321K in Q1 2026. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • denkapparat Operations held 6,202 shares of Supernus Pharmaceuticals worth $288K as of Q2 2026.
  • denkapparat Operations left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up 0.09% of denkapparat Operations's portfolio in Q2 2026, its #336 holding.
  • denkapparat Operations first reported a position in Supernus Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • denkapparat Operations's Supernus Pharmaceuticals position peaked at $321K in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.